Published in JAMA on December 12, 1990
British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax (2001) 3.95
Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother (1996) 2.22
The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis. Infect Immun (1992) 1.57
Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats. Infect Immun (1997) 1.38
Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats. Antimicrob Agents Chemother (1994) 1.16
Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions. Antimicrob Agents Chemother (2006) 0.97
Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis. Antimicrob Agents Chemother (1997) 0.89
Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci. Antimicrob Agents Chemother (1996) 0.87
Non-nosocomial healthcare-associated infective endocarditis in Taiwan: an underrecognized disease with poor outcome. BMC Infect Dis (2011) 0.87
Effects of antibiotics on dental implants: a review. J Clin Med Res (2012) 0.85
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. Antimicrob Agents Chemother (1997) 0.84
Long-term outlook in treated congenital heart disease. Arch Dis Child (1996) 0.82
A guide to antibiotics for the interventional radiologist. Semin Intervent Radiol (2005) 0.81
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. Antimicrob Agents Chemother (1996) 0.80
Is antibiotic prophylaxis ever necessary before transoesophageal echocardiography? Heart (2005) 0.79
RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci. Antimicrob Agents Chemother (1995) 0.78
Awareness of Iranian's General Dentists Regarding the Latest Prophylaxis Guideline for Prevention of Infective Endocarditis. J Dent (Shiraz) (2013) 0.78
Interactive clinical case: to give, or not to give, infective endocarditis prophylaxis. Heart Asia (2017) 0.77
Evolution of an idea: The case of prophylaxis against infective endocarditis. Ann Pediatr Cardiol (2012) 0.76
Is endocarditis prophylaxis for dental procedures necessary? Heart Asia (2017) 0.75
Antibiotic prophylaxis cards for bacterial endocarditis. Images Paediatr Cardiol (2000) 0.75
Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. Antimicrob Agents Chemother (1996) 0.75
Implementation and evaluation of a preprinted perioperative antimicrobial prophylaxis order form in a teaching hospital. Can J Infect Dis (1998) 0.75
Congenital heart disease in adults. West J Med (1995) 0.75
Prevention of bacterial endocarditis. JAMA (1991) 0.75
Prophylactic antibiotics in total joint arthroplasty. West J Med (1993) 0.75
Anesthesia in pregnancy with heart disease. Saudi J Anaesth (2017) 0.75
Anaesthetic management of the child with congenital heart disease for non-cardiac surgery. Can J Anaesth (1992) 0.75
Evaluation of Post-surgical Bacteremia with Use of Povidone-Iodine and Chlorhexidine During Mandibular Third Molar Surgery. J Maxillofac Oral Surg (2016) 0.75
Antibodies to ribosomes in chronic active hepatitis. Gastroenterology (1979) 12.78
Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun (1982) 9.97
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med (1994) 9.11
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol (1972) 8.33
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med (1991) 5.76
Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens. J Clin Invest (1973) 5.49
Infections in patients with diabetes mellitus. N Engl J Med (1999) 5.39
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1997) 5.24
Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol (1993) 5.14
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet (1986) 5.05
Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Ann Intern Med (1982) 5.03
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49
Characterization of clinically significant strains of coagulase-negative staphylococci. J Clin Microbiol (1983) 4.40
Chronic cryptococcal meningitis: a new experimental model in rabbits. Am J Pathol (1980) 4.28
Resistance of Neisseria gonorrhoeae to phagocytosis: relationship to colonial morphology and surface pili. J Infect Dis (1974) 4.15
Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations. Br J Exp Pathol (1972) 4.03
Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest (1985) 3.98
Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med (1983) 3.97
Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Pathol (1975) 3.96
Assessment and management of foot disease in patients with diabetes. N Engl J Med (1994) 3.83
Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits. Br J Exp Pathol (1973) 3.79
Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest (1988) 3.69
A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med (1992) 3.65
Diphtheroid prosthetic valve endocarditis. A study of clinical features and infecting organisms. Am J Med (1980) 3.59
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits. Antimicrob Agents Chemother (1986) 3.38
Prosthetic valve endocarditis. Analysis of 38 cases. Circulation (1973) 3.29
Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med (1999) 3.08
Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis. J Clin Invest (1975) 3.03
The neuroleptic malignant syndrome. Arch Intern Med (1982) 2.98
Long-term outcomes of persons with Lyme disease. JAMA (2000) 2.96
Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest (1990) 2.91
Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect Immun (1983) 2.85
International health and internal medicine residency training: the Duke University experience. Am J Med (1995) 2.83
Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr (1991) 2.82
Twenty-five-year experience with rastelli repair for transposition of the great arteries. J Thorac Cardiovasc Surg (2000) 2.80
Colonization with broad-spectrum cephalosporin-resistant gram-negative bacilli in intensive care units during a nonoutbreak period: prevalence, risk factors, and rate of infection. Crit Care Med (1999) 2.56
Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. JAMA (1976) 2.56
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med (1981) 2.56
Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.54
Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis (2001) 2.53
A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med (1993) 2.50
Alternate complement pathway activation by group A streptococci: role of M-protein. Infect Immun (1979) 2.39
Fulminant pneumococcal infections in 'normal' asplenic hosts. Arch Intern Med (1977) 2.37
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.35
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
Studies on the pink, adenine-deficient strains of Candida albicans. I. Cultural and morphological characteristics. Sabouraudia (1970) 2.29
Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis (1994) 2.29
Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains. J Clin Microbiol (1994) 2.23
Production of experimental endocarditis by coagulase-negative staphylococci: variability in species virulence. J Infect Dis (1984) 2.17
Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 2.15
Cryptococcemia. Medicine (Baltimore) (1983) 2.10
Group C beta-hemolytic streptococcal infections in children: nine pediatric cases and review. Rev Infect Dis (1989) 2.09
Opportunistic infections and Kaposi's sarcoma in homosexual men. N Engl J Med (1981) 2.09
Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA (1995) 2.09
Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis (2003) 2.06
Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity. J Immunol (1986) 2.06
Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages. Infect Immun (1981) 2.03
Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA (1989) 2.03
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. J Antimicrob Chemother (1985) 2.02
Absence of HIV transmission from an infected dentist to his patients. An epidemiologic and DNA sequence analysis. JAMA (1993) 2.01
Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J (1994) 1.99
Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis (1998) 1.97
Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci. J Clin Invest (1974) 1.96
Antibiotic tolerance among clinical isolates of bacteria. Antimicrob Agents Chemother (1986) 1.95
Infections associated with indwelling devices: concepts of pathogenesis; infections associated with intravascular devices. Antimicrob Agents Chemother (1989) 1.94
The aetiological agent of cat scratch disease. Lancet (1985) 1.93
Neurotoxicity of human eosinophils. Proc Natl Acad Sci U S A (1979) 1.89
Antigen detection test for streptococcal pharyngitis: evaluation of sensitivity with respect to true infections. J Pediatr (1986) 1.89
The weight of medical knowledge. N Engl J Med (1978) 1.87
Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci U S A (1981) 1.85
Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells. J Infect Dis (1987) 1.85
Identification of bipotential progenitor cells in human liver development. Hepatology (1996) 1.84
Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med (1996) 1.84
Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 1.80
Micronitrous acid extraction-coagglutination test for rapid diagnosis of streptococcal pharyngitis. J Clin Microbiol (1983) 1.79
Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis. Antimicrob Agents Chemother (1985) 1.78
Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304. Antimicrob Agents Chemother (1989) 1.78
Current practice in prevention of bacterial endocarditis. Br Heart J (1975) 1.78
Enterococcal endocarditis: a comparison of prosthetic and native valve disease. Rev Infect Dis (1991) 1.77
Abandoning empirical antibiotics for febrile children. Lancet (1997) 1.75
Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med (1984) 1.74